1. Garner R, Kohen D. Changes in the prevalence of asthma among Canadian children. Health Rep. 2008; 19:45–50.
2. Gibson PG, McDonald VM, Marks GB. Asthma in older adults. Lancet. 2010; 376:803–813. PMID:
20816547.

3. Moorman JE, Akinbami LJ, Bailey CM, Zahran HS, King ME, Johnson CA, et al. National surveillance of asthma: United States, 2001–2010. Vital Health Stat 3. 2012; 1–58. PMID:
24252609.
4. Tsai CL, Lee WY, Hanania NA, Camargo CA. Age-related differences in clinical outcomes for acute asthma in the United States, 2006–2008. J Allergy Clin Immunol. 2012; 129:1252–1258.e1. PMID:
22385630.

5. Szefler SJ. Asthma across the lifespan: time for a paradigm shift. J Allergy Clin Immunol. 2018; 142:773–780. PMID:
29627424.

6. Song WJ, Cho SH. Challenges in the management of asthma in the elderly. Allergy Asthma Immunol Res. 2015; 7:431–439. PMID:
26122503.

7. Park HW, Kim TW, Song WJ, Kim SH, Park HK, Kim SH, et al. Prediction of asthma exacerbations in elderly adults: results of a 1-year prospective study. J Am Geriatr Soc. 2013; 61:1631–1632. PMID:
24028367.

8. Park HW, Kwon HS, Kim TB, Kim SH, Chang YS, Jang AS, et al. Differences between asthma in young and elderly: results from the COREA study. Respir Med. 2013; 107:1509–1514. PMID:
23927852.
9. Sano H, Iwanaga T, Nishiyama O, Sano A, Higashimoto Y, Tomita K, et al. Characteristics of phenotypes of elderly patients with asthma. Allergol Int. 2016; 65:204–209. PMID:
26786397.

10. Inoue H, Niimi A, Takeda T, Matsumoto H, Ito I, Matsuoka H, et al. Pathophysiological characteristics of asthma in the elderly: a comprehensive study. Ann Allergy Asthma Immunol. 2014; 113:527–533. PMID:
25216975.

11. Ulambayar B, Lee SH, Yang EM, Ye YM, Park HS. Association between epithelial cytokines and clinical phenotypes of elderly asthma. Allergy Asthma Immunol Res. 2019; 11:79–89. PMID:
30479079.

12. Shoemaker JS, Painter IS, Weir BS. Bayesian statistics in genetics: a guide for the uninitiated. Trends Genet. 1999; 15:354–358. PMID:
10461203.

13. Ashby D. Bayesian statistics in medicine: a 25 year review. Stat Med. 2006; 25:3589–3631. PMID:
16947924.

14. Arora P, Boyne D, Slater JJ, Gupta A, Brenner DR, Druzdzel MJ. Bayesian networks for risk prediction using real-world data: a tool for precision medicine. Value Health. 2019; 22:439–445. PMID:
30975395.

15. Kim TB, Jang AS, Kwon HS, Park JS, Chang YS, Cho SH, et al. Identification of asthma clusters in two independent Korean adult asthma cohorts. Eur Respir J. 2013; 41:1308–1314. PMID:
23060627.

16. Kim TB, Park CS, Bae YJ, Cho YS, Moon HB. COREA Study Group. Factors associated with severity and exacerbation of asthma: a baseline analysis of the cohort for reality and evolution of adult asthma in Korea (COREA). Ann Allergy Asthma Immunol. 2009; 103:311–317. PMID:
19852195.

17. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009; 180:59–99. PMID:
19535666.
18. Purdy S, Griffin T, Salisbury C, Sharp D. Ambulatory care sensitive conditions: terminology and disease coding need to be more specific to aid policy makers and clinicians. Public Health. 2009; 123:169–173. PMID:
19144363.

19. Warner SM, Knight DA. Airway modeling and remodeling in the pathogenesis of asthma. Curr Opin Allergy Clin Immunol. 2008; 8:44–48. PMID:
18188017.

20. Barnes PJ. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2013; 131:636–645. PMID:
23360759.

21. Global Initiative for Asthma. Global strategy for asthma management and prevention [Internet]. Fontana (WI): Global Initiative for Asthma;2019. Available from:
http://ginasthma.org/gina-reports.
22. Kerstjens HA, Engel M, Dahl R, Paggiaro P, Beck E, Vandewalker M, et al. Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med. 2012; 367:1198–1207. PMID:
22938706.

23. Kim SW, Kim JH, Park CK, Kim TJ, Lee SY, Kim YK, et al. Effect of roflumilast on airway remodelling in a murine model of chronic asthma. Clin Exp Allergy. 2016; 46:754–763. PMID:
26542330.

24. Barua P, O'Mahony MS. Overcoming gaps in the management of asthma in older patients: new insights. Drugs Aging. 2005; 22:1029–1059. PMID:
16363886.
25. Kim YK, Kim SH, Tak YJ, Jee YK, Lee BJ, Kim SH, et al. High prevalence of current asthma and active smoking effect among the elderly. Clin Exp Allergy. 2002; 32:1706–1712. PMID:
12653160.

26. Park HW, Song WJ, Kim SH, Park HK, Kim SH, Kwon YE, et al. Classification and implementation of asthma phenotypes in elderly patients. Ann Allergy Asthma Immunol. 2015; 114:18–22. PMID:
25455518.

27. Sutherland ER, Goleva E, King TS, Lehman E, Stevens AD, Jackson LP, et al. Cluster analysis of obesity and asthma phenotypes. PLoS One. 2012; 7:e36631. PMID:
22606276.

28. Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010; 181:315–323. PMID:
19892860.

29. Amelink M, de Groot JC, de Nijs SB, Lutter R, Zwinderman AH, Sterk PJ, et al. Severe adult-onset asthma: a distinct phenotype. J Allergy Clin Immunol. 2013; 132:336–341. PMID:
23806634.

30. Bachert C, van Steen K, Zhang N, Holtappels G, Cattaert T, Maus B, et al. Specific IgE against Staphylococcus aureus enterotoxins: an independent risk factor for asthma. J Allergy Clin Immunol. 2012; 130:376–381.e8. PMID:
22738677.
31. Song WJ, Sintobin I, Sohn KH, Kang MG, Park HK, Jo EJ, et al. Staphylococcal enterotoxin IgE sensitization in late-onset severe eosinophilic asthma in the elderly. Clin Exp Allergy. 2016; 46:411–421. PMID:
26436720.

32. Morse JC, Li P, Ely KA, Shilts MH, Wannemuehler TJ, Huang LC, et al. Chronic rhinosinusitis in elderly patients is associated with an exaggerated neutrophilic proinflammatory response to pathogenic bacteria. J Allergy Clin Immunol. 2019; 143:990–1002.e6. PMID:
30468775.

33. Ulrik CS, Backer V. Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma. Eur Respir J. 1999; 14:892–896. PMID:
10573238.

34. ten Brinke AN, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH. Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med. 2001; 164:744–748. PMID:
11549526.

35. Milanese M, Di Marco F, Corsico AG, Rolla G, Sposato B, Chieco-Bianchi F, et al. Asthma control in elderly asthmatics. An Italian observational study. Respir Med. 2014; 108:1091–1099. PMID:
24958604.

36. Garin N, Koyanagi A, Chatterji S, Tyrovolas S, Olaya B, Leonardi M, et al. Global multimorbidity patterns: a cross-sectional, population-based, multi-country study. J Gerontol A Biol Sci Med Sci. 2016; 71:205–214. PMID:
26419978.

37. Kauppi P, Kupiainen H, Lindqvist A, Tammilehto L, Kilpeläinen M, Kinnula VL, et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma. 2011; 48:279–285. PMID:
21323613.

38. Chae EJ, Kim TB, Cho YS, Park CS, Seo JB, Kim N, et al. Airway measurement for airway remodeling defined by post-bronchodilator FEV1/FVC in asthma: investigation using inspiration-expiration computed tomography. Allergy Asthma Immunol Res. 2011; 3:111–117. PMID:
21461250.

39. Zeki AA, Schivo M, Chan A, Albertson TE, Louie S. The asthma-COPD overlap syndrome: a common clinical problem in the elderly. J Allergy (Cairo). 2011; 2011:861926. PMID:
22121384.
